ORS 432.520
Reporting requirement
- review of records
- special studies
(1)
Except as provided in subsection (2) of this section, any health care facility in which patients are diagnosed or provided treatment for cancer or benign or borderline tumors of the brain and central nervous system shall report each case of cancer or benign or borderline tumors of the brain and central nervous system to the Oregon Health Authority or its authorized representative within a time period and in a format prescribed by the authority. The authority may provide, at cost, reporting services to health care facilities. Health care facilities may also purchase reporting services from another facility or commercial vendor. If a health care facility is unable to report in conformance with the format and standards prescribed by the authority, the authority may, after consultation with the health care facility, elect to activate its reporting service for the facility. When activated, the authority may enter the facility, obtain the information and report it in conformance with the appropriate format and standards. In these instances, the facility shall reimburse the authority or its authorized representative for the cost of obtaining and reporting the information.(2)
Upon application to the authority by a health care facility, the authority shall grant to the health care facility an extension of time in which to meet the reporting requirements of this section. In no event shall the extension of time exceed one year from the date of application.(3)
Any licensed health care practitioner diagnosing or providing treatment to patients with cancer or benign or borderline tumors of the brain and central nervous system shall report each case to the authority or its authorized representative within a time period and in a format prescribed by the authority. Those cases diagnosed or treated at an Oregon health care facility or previously admitted to an Oregon health care facility for diagnosis or treatment of that instance of cancer or benign or borderline tumors of the brain and central nervous system shall be considered by the authority to have been reported by the licensed health care practitioner.(4)
Any clinical laboratory diagnosing cases of cancer or benign or borderline tumors of the brain and central nervous system shall report each case to the authority or its authorized representative within a time period and in a format prescribed by the authority.(5)
For the purpose of assuring the accuracy and completeness of reported data, the authority shall have the right to periodically review all records that would:(a)
Identify cases of cancer and benign or borderline tumors, the treatment of the cancer or benign or borderline tumors or the medical status of any patient identified as being treated for cancer or benign or borderline tumors; or(b)
Establish characteristics of the cancer or benign or borderline tumors.(6)
The authority may conduct special studies of cancer morbidity and mortality. As part of such studies, registry personnel may obtain additional information that applies to a patient’s cancer or benign or borderline tumors and that may be in the medical record of the patient. The record holder may either provide the requested information to the registry personnel or provide the registry personnel access to the relevant portions of the patient’s medical record. Neither the authority nor the record holder shall bill the other for the cost of providing or obtaining this information. [1995 c.585 §3; 2003 c.269 §3; 2009 c.595 §620; 2017 c.101 §37; 2019 c.456 §30]
Source:
Section 432.520 — Reporting requirement; review of records; special studies, https://www.oregonlegislature.gov/bills_laws/ors/ors432.html.
Up to date